Seth Hepner, MD
Neurology · Bridgeton, MONPI 1609131663
Payments from drug & device makers
Across 1,011 payments — averaging $401.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$236K
- Biohaven Pharmaceutical Holding Company Ltd.$134K
- Biohaven Pharmaceuticals, Inc.$18K
- Pfizer$13K
- MDD US Operations, LLC$714
- Neurocrine Biosciences, Inc.$483
- plus $3K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 690 | $236,179 |
| Biohaven Pharmaceutical Holding Company Ltd. | 133 | $134,194 |
| Biohaven Pharmaceuticals, Inc. | 37 | $18,287 |
| Pfizer | 79 | $12,846 |
| MDD US Operations, LLC | 4 | $714 |
| Neurocrine Biosciences, Inc. | 12 | $483 |
| SK Life Science, Inc. | 3 | $375 |
| Biogen | 7 | $307 |
| Eisai Inc. | 2 | $242 |
| Novartis | 7 | $241 |
| Sunovion Pharmaceuticals Inc. | 2 | $186 |
| E.r. Squibb & Sons, L.L.C. | 1 | $127 |
| Greenwich Biosciences, Inc. | 1 | $126 |
| Genentech USA, Inc. | 1 | $125 |
| Sanofi | 1 | $125 |
| AstraZeneca | 1 | $123 |
| Adamas Pharmaceuticals, Inc. | 1 | $122 |
| Amgen | 2 | $121 |
| Jazz Pharmaceuticals Inc. | 1 | $118 |
| Bristol Myers Squibb | 3 | $116 |
| Lundbeck LLC | 3 | $113 |
| Neurelis, Inc. | 1 | $105 |
| Averitas Pharma Inc. | 1 | $105 |
| Lilly USA, LLC | 5 | $69 |
| Upsher-smith Laboratories LLC | 2 | $51 |
| Argenx US, Inc. | 3 | $50 |
| EMD Serono, Inc. | 2 | $29 |
| Merz North America, Inc. | 2 | $27 |
| Bausch Health US, LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Medtronic | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $13 |
How this compares
$405,772 in reported general payments places this provider in the 90th percentile of 381 neurology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Bridgeton
- Siddharth KaulBridgeton$5.7M
- Daniel MattsonBridgeton$478K
- Randall BatemanSaint Louis$92.3M
- David HoltzmanSaint Louis$25.2M
- Robert NaismithSaint Louis$13.8M
- Eric McDadeSaint Louis$9.6M
- Robert BucelliSaint Louis$8.5M
- Barbara SniderSaint Louis$7M
- Curtis SchreiberBolivar$6.4M
- Gregory WuSaint Louis$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.